Breaking News Instant updates and real-time market news.

ARCE

Arco Platform

$48.15

0.75 (1.58%)

17:14
10/15/19
10/15
17:14
10/15/19
17:14

Arco Platform files $1B mixed securities shelf

ARCE Arco Platform
$48.15

0.75 (1.58%)

11/21/18
UBSW
11/21/18
INITIATION
Target $28
UBSW
Buy
Arco Platform initiated with a Buy at UBS
UBS analyst Maria Tereza Azevedo started Arco Platform with a Buy rating and $28 price target. The analyst views Arco as an "attractive investment proposition" given its "unique" product and market position in the private Brazilian K-12 learning system sector. She likes the company's software-as-a-service type and asset/regulatory-light business model.
11/21/18
11/21/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BeiGene (BGNE) initiated with an Overweight at JPMorgan. 2. Gamida Cell (GMDA) initiated with an Outperform at BMO Capital and Oppenheimer. 3. Marker Therapeutics (MRKR) initiated with a Buy at Nomura Instinet. 4. Arco Platform (ARCE) initiated with a Buy at UBS. 5. nVent Electric (NVT) initiated with a Hold at Vertical Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/19
FBCO
06/25/19
INITIATION
Target $46
FBCO
Neutral
Arco Platform initiated with a Neutral at Credit Suisse
Credit Suisse initiated Arco Platform with a Neutral and $46 price target.
08/29/19
BOFA
08/29/19
INITIATION
Target $58
BOFA
Buy
Arco Platform reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Pedro Mariani reinstated coverage of Arco Platform with a Buy rating and $58 price target, which implies 17% upside potential. Arco has developed a successful business model by creating a "win-win-win relationship" with schools, Mariani tells investors in a research note. He believes the company has strong brand equity in the Brazilian private K-12 education market. The analyst sees Arco leading the transformation of the K-12 segment, which he thinks should drive further market share expansion.

TODAY'S FREE FLY STORIES

TRVN

Trevena

$0.68

(0.00%)

07:15
11/20/19
11/20
07:15
11/20/19
07:15
Hot Stocks
Trevena announces publication of results from Phase 3 study of oliceridine »

Trevena announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:15
11/20/19
11/20
07:15
11/20/19
07:15
General news
FX Update: Risk-positioning has been underpinning the yen and the dollar »

FX Update:…

AVYA

Avaya

$12.11

-0.22 (-1.78%)

07:14
11/20/19
11/20
07:14
11/20/19
07:14
Earnings
Avaya reports Q4 EPS (31c), may not compare to consensus 84c »

Reports Q4 revenue $723M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CSOD

Cornerstone OnDemand

$60.24

0.78 (1.31%)

07:13
11/20/19
11/20
07:13
11/20/19
07:13
Conference/Events
Cornerstone OnDemand management to meet with DA Davidson »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

EMHTF

Emerald Health Therapeutics

$0.00

(0.00%)

, VFF

Village Farms

$6.27

0.19 (3.13%)

07:12
11/20/19
11/20
07:12
11/20/19
07:12
Hot Stocks
Emerald Health Therapeutics calls Village Farms allegations 'inaccurate' »

Emerald Health…

EMHTF

Emerald Health Therapeutics

$0.00

(0.00%)

VFF

Village Farms

$6.27

0.19 (3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

CRAI

CRA International

$50.07

-0.61 (-1.20%)

07:10
11/20/19
11/20
07:10
11/20/19
07:10
Conference/Events
CRA International management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 26

    Nov

  • 11

    Dec

TRVN

Trevena

$0.68

(0.00%)

07:09
11/20/19
11/20
07:09
11/20/19
07:09
Hot Stocks
Trevena announces publication of results from Phase 1 PK studies of oliceridine »

Trevena announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIO

Mustang Bio

$2.57

-0.06 (-2.28%)

07:09
11/20/19
11/20
07:09
11/20/19
07:09
Initiation
Mustang Bio initiated  »

Mustang Bio assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COWN

Cowen Group

$15.35

0.34 (2.27%)

07:08
11/20/19
11/20
07:08
11/20/19
07:08
Conference/Events
Cowen Group management to meet with Sandler ONeill »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LDOS

Leidos

$91.73

0.35 (0.38%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Hot Stocks
Leidos teams up with Pharicode on NEST contract to provide IT services to NASA »

Pharicode teamed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CO

Global Cord Blood

$4.56

-0.01 (-0.22%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Hot Stocks
Global Cord Blood comments on new Chinese regulation »

Global Cord Blood…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAVA

Endava

$44.07

-0.05 (-0.11%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Recommendations
Endava analyst commentary  »

Endava price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 26

    Nov

CI

Cigna

$200.06

1.645 (0.83%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Conference/Events
Cigna management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 09

    Dec

  • 06

    Feb

ROK

Rockwell Automation

$196.69

-0.95 (-0.48%)

, ANSS

Ansys

$242.54

3.87 (1.62%)

07:07
11/20/19
11/20
07:07
11/20/19
07:07
Hot Stocks
Rockwell Automation, Ansys announce strategic partnership »

Industrial companies now…

ROK

Rockwell Automation

$196.69

-0.95 (-0.48%)

ANSS

Ansys

$242.54

3.87 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 02

    Dec

  • 11

    Dec

BCLI

BrainStorm

$3.79

0.095 (2.57%)

07:06
11/20/19
11/20
07:06
11/20/19
07:06
Hot Stocks
BrainStorm announces publication of NurOwn ALS Phase 2 clinical trial data »

BrainStorm Cell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

JNJ

Johnson & Johnson

$134.81

-0.03 (-0.02%)

07:05
11/20/19
11/20
07:05
11/20/19
07:05
Initiation
Johnson & Johnson initiated  »

Cantor Fitzgerald starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 21

    Jan

ACB

Aurora Cannabis

$2.33

0.065 (2.87%)

07:05
11/20/19
11/20
07:05
11/20/19
07:05
Hot Stocks
Aurora Cannabis names Dr. Shane Morris CPO and Andre Jerome CIO »

Aurora Cannabis is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRRA

Sierra Oncology

$0.25

0.0095 (3.99%)

07:04
11/20/19
11/20
07:04
11/20/19
07:04
Hot Stocks
Sierra Oncology launches Momentum Phase 3 clinical trial in Myelofibrosis »

Sierra Oncology has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

TDG

TransDigm

$568.99

0.67 (0.12%)

07:04
11/20/19
11/20
07:04
11/20/19
07:04
Recommendations
TransDigm analyst commentary  »

TransDigm price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAV

Aravive

$6.69

0.19 (2.92%)

07:03
11/20/19
11/20
07:03
11/20/19
07:03
Hot Stocks
Aravive reports data from ongoing Phase 1b portion of AVB-500 trial »

Aravive announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANIX

Anixa Biosciences

$3.62

-0.135 (-3.60%)

07:03
11/20/19
11/20
07:03
11/20/19
07:03
Hot Stocks
Anixa Biosciences announces collaboration with Idaho Urologic Institute »

Anixa Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$205.94

-2.24 (-1.08%)

07:03
11/20/19
11/20
07:03
11/20/19
07:03
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:02
11/20/19
11/20
07:02
11/20/19
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 11/15 MBA…

BR

Broadridge

$122.16

1.55 (1.29%)

07:02
11/20/19
11/20
07:02
11/20/19
07:02
Hot Stocks
Broadridge acquires ClearStructure Financial Technology, terms not disclosed »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$56.48

-1.14 (-1.98%)

07:00
11/20/19
11/20
07:00
11/20/19
07:00
Hot Stocks
Bristol-Myers: Statistically significant benefit not reached in CheckMate -915 »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.